Mr. Philip Blake serves as Bayer HealthCare Representative U.S.A. at Bayer HealthCare LLC. Mr. Blake has been the Chief Executive Officer of Bayer Corporation since July 1, 2012 and serves as its President. Mr. Blake served as Head of Region Americas at Bayer HealthCare Pharmaceuticals Inc. since October 01, 2015 until March 15, 2017. Mr. Blake served as Head of Bayer - U.S. at Bayer AG since 2012. Mr. Blake served as the Chief Executive Officer and President at Bayer Inc. since 2002 and served as its Head of Bayer HealthCare for Canada. Mr. Blake served as General Manager of HealthCare Division at Bayers since 2000. He has wealth of business expertise, particularly in the area of drug development and medical countermeasures. He served in a number of senior management positions including global strategic product marketing, business development, clinical planning, product development and sales management. He developed and manufactures the antibiotic Cipro® (ciprofloxacin hydrochloride) deployed so effectively during the 2001 terrorist attack on Washington, D.C. He served as the Chairman of Canada’s Research-Based Pharmaceutical Companies since November 2006. He served as a Director at Nexia Biotechnologies Inc. since 2004. Mr. Blake serves as a Member of the Ivey Biotech Advisory Council at the University of Western Ontario's Richard Ivey School of Business. Mr. Blake is a Chartered Corporate Director, earning the prestigious designation in January 2006 from the Directors College at the DeGroote School of Business at McMaster University. He attended Bristol University and Oxford University Business School in England.

Business Administration